RAYMOND JAMES & ASSOCIATES - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 155 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$280,661
-6.9%
189,642
+1.2%
0.00%
Q2 2023$301,616
-44.9%
187,345
-0.8%
0.00%
Q1 2023$547,811
-8.1%
188,903
+4.0%
0.00%
-100.0%
Q4 2022$596,019
-14.5%
181,713
-1.4%
0.00%0.0%
Q3 2022$697,000
+37.2%
184,338
+182.6%
0.00%
Q2 2022$508,000
+151.5%
65,223
+174.4%
0.00%
Q1 2020$202,000
-42.1%
23,772
+12.3%
0.00%
Q4 2019$349,000
+22.0%
21,166
+4.6%
0.00%
Q3 2019$286,000
-30.4%
20,234
-1.1%
0.00%
-100.0%
Q2 2019$411,000
-60.1%
20,457
-21.1%
0.00%
-50.0%
Q1 2019$1,030,000
+15.3%
25,912
+0.8%
0.00%0.0%
Q4 2018$893,000
-17.0%
25,715
-1.2%
0.00%0.0%
Q3 2018$1,076,000
+10.9%
26,030
-1.4%
0.00%0.0%
Q2 2018$970,000
-10.9%
26,405
-5.5%
0.00%0.0%
Q1 2018$1,089,000
+137.8%
27,932
+10.3%
0.00%
+100.0%
Q4 2017$458,000
+17.1%
25,325
+7.3%
0.00%0.0%
Q3 2017$391,000
+18.5%
23,606
+0.1%
0.00%0.0%
Q2 2017$330,000
-20.9%
23,594
+16.2%
0.00%0.0%
Q1 2017$417,000
+62.9%
20,303
+12.7%
0.00%0.0%
Q4 2016$256,00018,0210.00%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Antipodean Advisors LLC 1,000,000$3,280,00010.95%
M28 Capital Management LP 439,300$1,440,9041.37%
Redmile Group, LLC 6,242,756$20,476,2400.84%
MAVERICK CAPITAL LTD 6,291,013$20,634,5230.49%
Baupost Group 8,123,616$26,6450.44%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 52,000$1710.25%
WASATCH ADVISORS LP 8,391,014$27,522,5250.18%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$1,722,0000.17%
STALEY CAPITAL ADVISERS INC 450,000$1,4760.09%
Virtus ETF Advisers LLC 36,100$118,4080.06%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders